Delivery Order SPE2DB22D3401-SPE2DB24FT3WB

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4568685400 - NALOXONE 4 MG/10 ML VIAL 10ML. The contract has a firm fixed price, with a ceiling value of $3,081.70, and an ultimate completion date of July 2, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The $3,091.99 firm-fixed-price contract is for the delivery of NALOXONE 0.4 MG/ML VIA, with a completion date of June 25, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,620.95, is for the delivery of 4567703648 NALOXONE 4 MG/10 ML VIAL 10ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 27, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NALOXONE 0.4 MG/ML VIALML. The contract has a ceiling value of $2,231.07 and is a firm fixed-price delivery order with a period of performance ending on July 2, 2025. The contract is not set-aside and was awarded on July 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,660 units of 10 milliliter vials of the opioid overdose reversal medication naloxone, with a ceiling value of $11,649.85. The contract is a firm fixed-price, non-set-aside award with a performance period extending through June 30, 2025. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,997.43, is for the delivery of 4,563,961,640 units of naloxone 0.4mg/10ml solution in boxes of 10. This is a Firm Fixed Price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,097.84, is for the delivery of 0.4 mg/mL vials of the opioid antagonist drug naloxone. This is a firm fixed-price delivery order contract with a period of performance through March 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naloxone 2 mg/2 ml syringes, with a ceiling value of $1,224.45 and a period of performance through June 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of naloxone 0.4 mg/ml vials, a medication used to treat opioid overdose. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,917.14 and a performance period through July 3, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp also holds a larger...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Naloxone 2 mg/2 ml syringes. The $1,486.13 Firm Fixed Price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT3WB
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,163.41, is for the delivery of 4565178934 - NALOXONE 4 MG/10 ML VIAL 10ML. It is a firm fixed-price contract with a completion date of July 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:14 AM